Physician

Aman Y Upadhyay, M.D.

According to 2025 Medicare claims, Aman Upadhyay, M.D. (NPI: 1598920886) practices pain management in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is PAIN CLINIC MANAGEMENT GROUP, PLLC (NPI: 1225302821; TIN: 454023977) and primary practice location at 48309-3607.

Upadhyay's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 509 traditional Medicare patients, billed 3,887 HCPCS/CPT codes, and received $390,472 in Medicare payments. The top billing code was G0482 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 4,357 prescription claims across 781 beneficiaries totaling $157,922 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). 2021 DME data shows 11 claims. Open Payments data shows 57 records totaling $11,455. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $62,703 to $390,472. Similarly, Part D prescription costs have moved sharply higher in recent years, from $52,761 to $157,922. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	356	1,195	$62,703
2016	316	1,142	$62,489
2017	299	1,207	$68,791
2018	302	915	$64,075
2019	239	775	$52,785
2020	148	1,217	$124,558
2021	344	2,936	$340,458
2022	390	3,865	$398,585
2023	497	4,303	$418,611
2024	509	3,887	$390,472

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	237	925	$52,761
2016	274	1,258	$49,345
2017	256	1,162	$47,749
2018	241	995	$59,252
2019	173	704	$58,723
2020	231	1,959	$106,102
2021	489	4,857	$223,264
2022	722	5,223	$245,888
2023	730	4,154	$164,493
2024	781	4,357	$157,922

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	12	$2,002
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	11	$1,096
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	290	598	$194
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	83	83	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	428	1,819	$91
62323	Injection of substance into lower spine canal using imaging guidance	30	47	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	214	680	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1,163	31,493	$26,491
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	689	19,709	$18,527
Diclofenac Potassium	Diclofenac Potassium	15	406	$14,084
Movantik	Naloxegol Oxalate	19	570	$7,620
Pregabalin	Pregabalin	132	4,260	$5,462

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	57	$11,455	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aman Y. Upadhyay, M.D.?

Tedicare shows public-source Medicare data for Aman Y. Upadhyay, M.D. (NPI 1598920886), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aman Y. Upadhyay, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aman Y. Upadhyay, M.D.?

Aman Y. Upadhyay, M.D. is linked to PAIN CLINIC MANAGEMENT GROUP, PLLC (billing NPI 1225302821) in the available physician profile data.

Does Aman Y. Upadhyay, M.D. have Open Payments data?

Aman Y. Upadhyay, M.D. has 57 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.